These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29164928)

  • 41. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clozapine and associated diabetes mellitus.
    Popli AP; Konicki PE; Jurjus GJ; Fuller MA; Jaskiw GE
    J Clin Psychiatry; 1997 Mar; 58(3):108-11. PubMed ID: 9108812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.
    Tiihonen J; Wahlbeck K; Lönnqvist J; Klaukka T; Ioannidis JP; Volavka J; Haukka J
    BMJ; 2006 Jul; 333(7561):224. PubMed ID: 16825203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.
    Hägg S; Joelsson L; Mjörndal T; Spigset O; Oja G; Dahlqvist R
    J Clin Psychiatry; 1998 Jun; 59(6):294-9. PubMed ID: 9671341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased cardiovascular risk with second-generation antipsychotic agent switches.
    Ried LD; Renner BT; McConkey JR; Bengtson MA; Lopez LM
    J Am Pharm Assoc (2003); 2006; 46(4):491-8; quiz 499-501. PubMed ID: 16913393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
    Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
    CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context.
    Malhi G; Adams D; Plain J; Coulston C; Herman M; Walter G
    Australas Psychiatry; 2010 Feb; 18(1):32-41. PubMed ID: 20039791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clozapine and mortality: A comparison with other antipsychotics in a nationwide Danish cohort study.
    van der Zalm Y; Foldager L; Termorshuizen F; Sommer IE; Nielsen J; Selten JP
    Acta Psychiatr Scand; 2021 Mar; 143(3):216-226. PubMed ID: 33306211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clozapine use in geriatric patients- Challenges.
    Mukku SSR; Sivakumar PT; Varghese M
    Asian J Psychiatr; 2018 Mar; 33():63-67. PubMed ID: 29529421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood Pressure and Heart Rate Changes During Clozapine Treatment.
    Norman SM; Sullivan KM; Liu F; DiPaula BA; Jose PA; Kitchen CA; Feldman SM; Kelly DL
    Psychiatr Q; 2017 Sep; 88(3):545-552. PubMed ID: 27678498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetes mellitus associated with clozapine therapy.
    Wehring H; Alexander B; Perry PJ
    Pharmacotherapy; 2000 Jul; 20(7):844-7. PubMed ID: 10907975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder.
    Hanssens L; van Winkel R; Wampers M; Van Eyck D; Scheen A; Reginster JY; Collette J; Peuskens J; De Hert M
    Schizophr Res; 2008 Dec; 106(2-3):308-14. PubMed ID: 18930377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A naturalistic pilot study comparing haloperidol, clozapine, sertindole, and risperidone in partially responsive chronic schizophrenia or schizoaffective disorder.
    Fogelson DL; Sternbach H; Payne D
    J Clin Psychopharmacol; 1997 Dec; 17(6):492-4. PubMed ID: 9408817
    [No Abstract]   [Full Text] [Related]  

  • 55. [Diabetes mellitus after treatment with clozapine].
    Brugman NJ; Cohen D; de Vries RH
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):437-9. PubMed ID: 10719549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does clozapine cause tardive dyskinesia?
    Kane JM; Woerner MG; Pollack S; Safferman AZ; Lieberman JA
    J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data.
    Rajagopalan K; Hassan M; O'Day K; Meyer K; Grossman F
    J Med Econ; 2013 Jul; 16(7):951-61. PubMed ID: 23701260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach.
    Lund BC; Perry PJ; Brooks JM; Arndt S
    Arch Gen Psychiatry; 2001 Dec; 58(12):1172-6. PubMed ID: 11735847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes as a result of atypical anti-psychotic drugs--a report of three cases.
    Rigalleau V; Gatta B; Bonnaud S; Masson M; Bourgeois ML; Vergnot V; Gin H
    Diabet Med; 2000 Jun; 17(6):484-6. PubMed ID: 10975220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
    Landry P; Dimitri E; Tessier S; Légaré N
    J Clin Psychopharmacol; 2008 Jun; 28(3):348-9. PubMed ID: 18480696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.